These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1316683)

  • 1. Infection of the HTLV-I-harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus.
    Koizumi S; Zhang XK; Imai S; Sugiura M; Usui N; Osato T
    Virology; 1992 Jun; 188(2):859-63. PubMed ID: 1316683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3d and Epstein-Barr virus (CR2/CD21 ligands) stimulate cells of an HTLV-I line, MT-2.
    Kuraya M; Sato T; Fujita T
    Microbiol Immunol; 1995; 39(2):145-51. PubMed ID: 7783687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
    Ohtsubo H; Arima N; Matsushita K; Hidaka S; Fujiwara H; Arimura K; Kukita T; Fukumori J; Matsumoto T; Eizuru Y; Tanaka H
    Exp Hematol; 1997 Nov; 25(12):1246-52. PubMed ID: 9357968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of the human T-cell-derived leukemia line Molt-4 by Epstein-Barr virus (EBV): induction of EBV-determined antigens and virus reproduction.
    Shapiro IM; Volsky DJ; Saemundsen AK; Anisimova E; Klein G
    Virology; 1982 Jul; 120(1):171-81. PubMed ID: 6285596
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
    Hedrick JA; Watry D; Speiser C; O'Donnell P; Lambris JD; Tsoukas CD
    Eur J Immunol; 1992 May; 22(5):1123-31. PubMed ID: 1315687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21.
    Yoshiyama H; Imai S; Shimizu N; Takada K
    J Virol; 1997 Jul; 71(7):5688-91. PubMed ID: 9188650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
    Peng M; Lundgren E
    Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus infection and replication in a human epithelial cell system.
    Li QX; Young LS; Niedobitek G; Dawson CW; Birkenbach M; Wang F; Rickinson AB
    Nature; 1992 Mar; 356(6367):347-50. PubMed ID: 1312681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell phenotype (CD23)-dependent variation in EBV genome copy numbers within lymphoblastoid cell lines (LCL).
    Wendel-Hansen V; Tao W; Ericson M; Klein G; Rosén A
    Int J Cancer; 1992 Feb; 50(4):589-92. PubMed ID: 1311286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
    Takimoto T; Umeda R; Glaser R
    Acta Virol; 1989 Aug; 33(4):375-7. PubMed ID: 2574946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC; Frazier B; Ley TJ; Holers VM
    J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus.
    Gosselin J; Menezes J; D'Addario M; Hiscott J; Flamand L; Lamoureux G; Oth D
    Eur J Immunol; 1991 Jan; 21(1):203-8. PubMed ID: 1846816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
    Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB
    J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
    J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human thymocytes after infection by EBV.
    Paterson RL; Kelleher CA; Streib JE; Amankonah TD; Xu JW; Jones JF; Gelfand EW
    J Immunol; 1995 Feb; 154(3):1440-9. PubMed ID: 7822809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of adult T-cell leukemia virus reproduction in B-cell lines and it's interaction with the Epstein-Barr herpesvirus].
    Iakovleva LS; Pavlish OA; Syrtsev AV; Galetskiĭ SA; Dushen'kina TE; Gurtsevich VE
    Vopr Virusol; 1997; 42(2):77-81. PubMed ID: 9182405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and characterization of Epstein-Barr virus-infected clones of a human T-lymphoblastoid cell line].
    Fujiwara S; Nakamura H; Iwakiri D; Ono Y
    Nihon Rinsho; 1997 Feb; 55(2):416-23. PubMed ID: 9046834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.